Acumen Pharmaceuticals Inc (ABOS)
3.655
-0.08
(-2.01%)
USD |
NASDAQ |
May 17, 16:00
3.655
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Cash from Operations (Quarterly): -17.86M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -17.86M |
| December 31, 2023 | -8.314M |
| September 30, 2023 | -12.90M |
| June 30, 2023 | -11.67M |
| March 31, 2023 | -10.18M |
| December 31, 2022 | -11.20M |
| September 30, 2022 | -9.183M |
| June 30, 2022 | -6.468M |
| March 31, 2022 | -8.299M |
| Date | Value |
|---|---|
| December 31, 2021 | -3.639M |
| September 30, 2021 | -7.688M |
| June 30, 2021 | -4.264M |
| March 31, 2021 | -2.37M |
| December 31, 2020 | -2.857M |
| September 30, 2020 | -1.283M |
| June 30, 2020 | -1.494M |
| March 31, 2020 | -1.816M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.86M
Minimum
Mar 2024
-1.283M
Maximum
Sep 2020
-7.146M
Average
-7.688M
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| Accuray Inc | -8.102M |
| Kezar Life Sciences Inc | -22.86M |
| Akoya Biosciences Inc | -20.82M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -9.203M |
| Cash from Financing (Quarterly) | 7.107M |
| Free Cash Flow | -50.78M |
| Free Cash Flow Per Share (Quarterly) | -0.2988 |
| Free Cash Flow Yield | -26.12% |